GENPF (Genix Pharmaceuticals) Total Inventories: $0.00 Mil (As of Jan. 2026)


What is Genix Pharmaceuticals Total Inventories?

Genix Pharmaceuticals GENPF Total Inventories is $0.00 Mil as of Jan. 2026. The stock has 3 warning signs investors should review.

Genix Pharmaceuticals's total inventories for the quarter that ended in Jan. 2026 was $0.00 Mil. Genix Pharmaceuticals's average total inventories from the quarter that ended in Oct. 2025 to the quarter that ended in Jan. 2026 was $0.00 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Genix Pharmaceuticals's Net-Net Working Capital per share for the quarter that ended in Jan. 2026 was $-0.02.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


Genix Pharmaceuticals  (OTCPK:GENPF) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Genix Pharmaceuticals's Net-Net Working Capital Per Share for the quarter that ended in Jan. 2026 is

Net-Net Working Capital Per Share (Q: Jan. 2026 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.009+0.75 * 0.001+0.5 * 0-1.094
-0-0)/61.224
=-0.02

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Genix Pharmaceuticals's Days Inventory for the three months ended in Jan. 2026 is calculated as:

Days Inventory=Average Total Inventories (Q: Jan. 2026 )/Cost of Goods Sold (Q: Jan. 2026 )*Days in Period
=0/0*365 / 4
=

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Genix Pharmaceuticals's Inventory Turnover for the quarter that ended in Jan. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Jan. 2026 ) / Average Total Inventories (Q: Jan. 2026 )
=0 / 0
=N/A

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Genix Pharmaceuticals's Inventory to Revenue for the quarter that ended in Jan. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Jan. 2026 ) / Revenue (Q: Jan. 2026 )
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Genix Pharmaceuticals Total Inventories Related Terms


Genix Pharmaceuticals Total Inventories Historical Data

* Premium members only.

The historical data trend for Genix Pharmaceuticals's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genix Pharmaceuticals Total Inventories Chart

Genix Pharmaceuticals Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Total Inventories
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.13 0.12 0.00 0.00

Genix Pharmaceuticals Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Genix Pharmaceuticals Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →
What does a Total Inventories of $0.00 Mil mean?
Genix Pharmaceuticals (GENPF) has a Total Inventories of $0.00 Mil as of Jan. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for Genix Pharmaceuticals and its competitors.
Is Genix Pharmaceuticals' Total Inventories too high?
Genix Pharmaceuticals' current Total Inventories is $0.00 Mil.
How does Genix Pharmaceuticals' Total Inventories compare to ZTS and UTHR?
Genix Pharmaceuticals' Total Inventories of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Drug Manufacturers company?
A good Total Inventories depends on the Drug Manufacturers industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Genix Pharmaceuticals and its competitors. Genix Pharmaceuticals's current Total Inventories is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genix Pharmaceuticals stock overvalued right now?
Genix Pharmaceuticals (GENPF) has a current Total Inventories of $0.00 Mil. The current Total Inventories is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Genix Pharmaceuticals (GENPF), the current Total Inventories is $0.00 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genix Pharmaceuticals Business Description

Other Exchanges GENX:Canada
Address 1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 1J8
Genix Pharmaceuticals Corp is a Canadian life sciences company focused on the research, development, manufacturing, sales, and distribution of novel, branded generic ophthalmic drugs, and ophthalmic OTC products. It operates as a formulator, manufacturer, licensor, and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its ophthalmic products portfolio comprises different kinds of eye ointments (pending approval), and eye drops. Geographically the company operates only in Canada.